Showing results (171-180 of 340) with videos related to
Sort By:
Pageof 34
Journal of Gastroenterology and Hepatology|May 25, 2010
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological responseChung-Feng Huang, Jeng-Fu Yang, Jee-Fu Huang, et al.Hepatology International|July 24, 2015
Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapyChun-Hao Chen, Jee-Fu Huang, Chung-Feng Huang, et al.Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.Hepatology (Baltimore, Md.)|May 30, 2008
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trialMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.Oncotarget|March 16, 2018
The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infectionChia-Yen Dai, Yi-Shan Tsai, Wen-Wen Chou, et al.The Kaohsiung Journal of Medical Sciences|October 6, 2020
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancyMing-Lun Yeh, Hsing-Tao Kuo, Ching-I Huang, et al.Medicine|October 27, 2015
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized StudyMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2017
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanMeng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, et al.The Kaohsiung Journal of Medical Sciences|February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinomaChih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.Journal of Hepatology|November 9, 2010
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trialJee-Fu Huang, Ming-Lung Yu, Chung-Feng Huang, et al.Pageof 34